TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION

Patent Owner

Follow Compare Add to Portfolio 4Status Updates

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 73169
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 19167
 
 
 
C07D HETEROCYCLIC COMPOUNDS 16125
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1377
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 13115
 
 
 
C07K PEPTIDES 1299
 
 
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 11124
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1087
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 8149
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 8109

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0016,941 NOVEL 5-HYDROXYTRYPTAMINE RECEPTOR 7 ACTIVITY MODULATORS AND THEIR METHOD OF USEMar 11, 14Jan 21, 16[C07D]
2016/0017,301 METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTIONAug 29, 14Jan 21, 16[C12N, A61K]
2016/0018,403 STABILIZED PEPTIDE FRAGMENTS FROM REDOXIN PROTEINS AS CANCER BIOMARKERSJul 15, 15Jan 21, 16[G01N, C07K]
2015/0366,993 COMPOSITIONS AND METHODS FOR TREATMENT OF CANCEROct 16, 13Dec 24, 15[A61K]
2015/0291,539 DISUBSTITUTED OXAZOLIDIN-2-ONES 5-HYDROXYTRYPTAMINE RECEPTOR 2B ACTIVITY MODULATORSNov 26, 13Oct 15, 15[C07D]
2015/0265,561 TREATMENT OF DISORDERS ASSOCIATED WITH G PROTEIN-COUPLED RECEPTOR 35 (GPR35)May 13, 15Sep 24, 15[A61K]
2015/0266,819 SUBSTITUTED ALKYL DIARYL DERIVATIVES, METHODS OF PREPARATION AND USESSep 18, 13Sep 24, 15[C07D, C07C]
2015/0190,463 USE OF ISOLATED BACTERIAL AMYLOIDS FOR TREATMENT OF INFLAMMATORY DISORDERS OR DISEASES OF THE EPITHELIUMJun 12, 13Jul 09, 15[A61K]
2015/0175,649 SYNTHETIC pGpG ANALOGS, METHODS OF PREPARATION AND METHODS OF USEJun 17, 13Jun 25, 15[C07H, G01N]
2015/0147,766 METHOD FOR DETERMINING DISEASE SEVERITY IN TAUOPATHY-RELATED NEURODEGENERATIVE DISORDERSMay 23, 13May 28, 15[C12Q, G01N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9,233,095 Small molecule RNase inhibitors and methods of useJan 26, 12Jan 12, 16[C07D, A61K]
9,198,446 Chocolate production method and apparatusMay 11, 15Dec 01, 15[A23C, A23G]
9,163,088 Tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia veraOct 26, 07Oct 20, 15[C07K]
9,140,704 Serum markers associated with early and other stages of breast cancerJul 13, 10Sep 22, 15[G01N, C07K]
9,089,545 Small molecule RNase inhibitors and methods of useJan 26, 12Jul 28, 15[C07D, A61K]
9,073,965 Adiponectin receptor agonists and methods of useApr 11, 12Jul 07, 15[A61K, C07K]
9,044,036 Chocolate production method and apparatusJan 31, 13Jun 02, 15[A23C, A23G]
9,040,583 Treatment of disorders associated with G protein-coupled receptor 35 (GPR35)Jul 14, 10May 26, 15[A61K]
9,001,325 Filament-based stimulated Raman detectionFeb 03, 12Apr 07, 15[G01J, G01N]
8,987,267 ]pyrimidine-6-carbonitriles and uses thereof in treating proliferative disordersJul 21, 11Mar 24, 15[C07D, A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0065,499 3-AMINOTHIENO[3,2-c]QUINOLINE DERIVATIVES, METHODS OF PREPARATION AND USESABANFeb 26, 13Mar 05, 15[C07D]
2012/0258,539 USE OF NIBP POLYPEPTIDESABANOct 12, 10Oct 11, 12[C12N]
2012/0017,467 ORTHOTIC SHOE AND INSOLE ASSEMBLIESABANOct 26, 09Jan 26, 12[A43B]
2011/0294,698 PROCESS FOR IDENTIFYING DRUGS FOR TREATING GASTROESOPHAGEAL REFLUXABANJun 21, 11Dec 01, 11[C40B, C12Q, G01N]
2010/0284,921 TARGETED NANOPARTICLES FOR INTRACELLULAR CANCER THERAPYABANMay 10, 10Nov 11, 10[A61P, G01N, A61K]
2010/0204,673 OBESITY CONTROLLING METHODABANSep 25, 09Aug 12, 10[A61M]
2010/0042,322 MODULAR NAVIGATION SYSTEM AND METHODSABANDec 11, 07Feb 18, 10[G01C]
7,635,561 Methods of diagnosing, prognosing and treating breast cancerExpiredJun 01, 04Dec 22, 09[C12Q, G01N]
2009/0270,479 Genetic and Epigenetic Alterations In the Diagnosis and Treatment of CancerABANDec 20, 05Oct 29, 09[C07H, A61P, C12Q, A61K, C07K]
2009/0208,450 METHOD FOR ENHANCING THE EFFICACY OF ANTIGEN SPECIFIC TUMOR IMMUNOTHERAPYABANAug 24, 07Aug 20, 09[C12Q, A61K]
7,575,858 Method of visualizing proteins bound to protein-binding membranesExpiredSep 09, 03Aug 18, 09[C12Q]
2009/0191,193 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses ThereofABANAug 01, 07Jul 30, 09[A61P, C07C, A61K, C07K]
2009/0138,979 MANIPULATING SP1 ACTIVITY TO IMPROVE THERAPEUTIC CLONINGABANNov 25, 08May 28, 09[C12N]
2009/0117,155 TREATMENT OF HIV-1 BY MODULATION OF VPR ACTIVATION OF THE M-CSF PROMOTERABANMay 24, 07May 07, 09[C12N, C12Q, A61K]
2008/0318,216 Methods For Determining Presence of Cancer by Analyzing the Expression of Cdk9 and/or Cyclin T1 in Lymphoid TissueABANJul 12, 05Dec 25, 08[C12Q, G01N]
2008/0208,765 METHOD AND APPARATUS FOR COMPARISON OF VARIABLE TERM FINANCIAL INSTRUMENTS USING LIFE EXTENSION DURATION COMPUTATIONABANFeb 28, 07Aug 28, 08[G06Q]
7,329,641 Blood substitutesExpiredNov 01, 04Feb 12, 08[C07K]
2007/0213,394 Salvinorin derivatives and uses thereofABANSep 29, 06Sep 13, 07[C07D, A61K]
2007/0104,756 Obesity controlling methodABANJun 29, 06May 10, 07[A61F]
7,101,343 Implantable telemetric monitoring system, apparatus, and methodExpiredNov 05, 03Sep 05, 06[A61B]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.